Advent Access wins CE Mark for dialysis device
PUBLISHED: 05 Jul 2019
Congratulations to Advent Access on winning the European CE Mark regulatory approval for dialysis device, the av-Guardian. The av-GuardianTM is the world’s first implant technology to pioneer the concept of establishing a “guardian guide-door” to facilitate dialysis needles to optimally access the dialysis vein, an arteriovenous fistula (AV fistula), without being in contact with the vein. The technology may be used in a dialysis center or at home, regardless of the types of dialysis machine being used.
You can find out more here.